Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac140Source: DataRank Database

A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection is a research paper published in Open Forum Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.42)OA: goldTopics (23)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Weixiao Dai ORCID,Dafna Yahav ORCID,Toshimitsu Hamasaki ORCID,‪Adi Turjeman‬‏ORCID,Fidi Koppel

Live enrichment

PubMed:35615299 PMC:PMC9125302 OpenAlex:https://openalex.org/W4226147252

National Institute of Allergy and Infectious Diseases

Grant: UM1AI104681

National Institutes of Health

Grant: 5UM1AI104681-03

Antibacterial Resistance Leadership Group (ARLG)

Antibacterial Resistance Leadership Group

FWCI

1.42

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://academic.oup.com/ofid/article-pdf/9/6/ofac140/43781916/ofac140.pdf

publisherhttps://academic.oup.com/ofid/article-pdf/9/6/ofac140/43781916/ofac140.pdf

publisherhttps://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofac140/43350350/ofac140.pdf

journalhttps://doi.org/10.1093/ofid/ofac140

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35615299

Fields of Study

Antibiotic Use and ResistanceSepsis Diagnosis and TreatmentBacterial Identification and Susceptibility Testing03 medical and health sciences0302 clinical medicine

Keywords

MedicineGramAntibioticsRandomized controlled trialBloodstream infectionInternal medicineRanking (information retrieval)Intensive care medicinePediatricsMicrobiologyBacteriaBiologyArtificial intelligenceTreatment DurationGram-negative BacteremiaDesirability Of Outcome RankingGram-negative bacteremia; antibiotics; desirability of outcome ranking; treatment durationMajor Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being